CID 5291

Imatinib

Structural Information

Molecular Formula
C29H31N7O
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
InChI
InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)
InChIKey
KTUFNOKKBVMGRW-UHFFFAOYSA-N
Compound name
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
Related CIDs

2D Structure

compound 2d structure
8
Annotation Hits

15596
References

141022
Patents

493.259 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 494.26628 223.2
[M+Na]+ 516.24822 226.2
[M-H]- 492.25172 230.7
[M+NH4]+ 511.29282 221.0
[M+K]+ 532.22216 216.5
[M+H-H2O]+ 476.25626 206.4
[M+HCOO]- 538.25720 235.6
[M+CH3COO]- 552.27285 227.0
[M+Na-2H]- 514.23367 225.0
[M]+ 493.25845 217.7
[M]- 493.25955 217.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe